The peptide-capped gold cluster (Au25Sv9) selectively targets abnormal oxidative stress in CLL cells to specifically block thioredoxin reductase (TrxR) activity, leading to substantial apoptosis. Here, PRDX5 is linked to B-cell chronic lymphocytic leukemia.